3C-DFM

Pharmaceutical compound From Wikipedia, the free encyclopedia

3C-DFM, also known as 4-(2,2-difluoromethoxy)-3,5-dimethoxyamphetamine or as or as α-methyldifluoromescaline (3C-difluoromescaline), is a serotonin receptor modulator of the phenethylamine and 3C families.[1][2][3] It is the amphetamine (α-methyl) derivative of the psychedelic drug difluoromescaline (DFM).[1][2][3] The properties and effects of 3C-DFM in humans are unknown.[1][2] The drug shows affinity for the serotonin 5-HT2 receptors and is known to act as an agonist of the serotonin 5-HT2A and 5-HT2B receptors.[3][2] 3C-DFM was first described in the scientific literature by Daniel Trachsel by 2012.[2][1][3] It is a controlled substance in Ukraine.[4] The drug is also a controlled substance in Canada under phenethylamine blanket-ban language.[5]

Other names3C-Difluoromescaline; α-Methyldifluoromescaline; 4-(2,2-Difluoromethoxy)-3,5-dimethoxyamphetamine; 3,5-Dimethoxy-4-(2,2-difluoromethoxy)amphetamine; 4-Difluoromethoxy-3,5-dimethoxyamphetamine; 3,5-Dimethoxy-4-difluoromethoxyamphetamine
ATC code
  • None
Quick facts Clinical data, Other names ...
3C-DFM
Clinical data
Other names3C-Difluoromescaline; α-Methyldifluoromescaline; 4-(2,2-Difluoromethoxy)-3,5-dimethoxyamphetamine; 3,5-Dimethoxy-4-(2,2-difluoromethoxy)amphetamine; 4-Difluoromethoxy-3,5-dimethoxyamphetamine; 3,5-Dimethoxy-4-difluoromethoxyamphetamine
Drug classSerotonin receptor modulator; Serotonin 5-HT2A receptor agonist
ATC code
  • None
Identifiers
  • 1-[4-(difluoromethoxy)-3,5-dimethoxyphenyl]propan-2-amine
PubChem CID
ChemSpider
Chemical and physical data
FormulaC12H17F2NO3
Molar mass261.269 g·mol−1
3D model (JSmol)
  • CC(CC1=CC(=C(C(=C1)OC)OC(F)F)OC)N
  • InChI=1S/C12H17F2NO3/c1-7(15)4-8-5-9(16-2)11(18-12(13)14)10(6-8)17-3/h5-7,12H,4,15H2,1-3H3
  • Key:BQVYKMZBEBFRIG-UHFFFAOYSA-N
Close

See also

References

Related Articles

Wikiwand AI